Gestalt Diagnostics: Algorithm for Use on Eight Types of Cancer Trained on Seven Scanner Models SPOKANE, Wash., Sept. 19, 2023 /PRNewswire/ -- Gestalt Diagnostics is proud to announce our latest release – an AI algorithm for use on one of...

Paige Colon MSI supports pathologists in the detection of MSI status using H&E-stain alone NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing...

Gestalt Diagnostics: PAIP 2023 Challenge Winner and MICCAI 2022 ACROBAT Challenge Winner SPOKANE, Wash., April 21, 2023 /PRNewswire/ -- Gestalt Diagnostics is honored to have taken 1st place in both International challenges. Hundreds of...

Albuquerque, NM, and Glasgow, Scotland, – 30 August, 2022 – Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The Industrial Centre for Artificial Intelligence Research in Digital...

Proscia and Visiopharm: Partnership to improve clinical decision making for breast and colon cancer care HOERSHOLM, Denmark & PHILADELPHIA – March 22, 2022 – Proscia®, a leader in digital and computational pathology solutions, and...

New software built in Japan can detect bowel cancer in less than a second. The AI-powered system, built in Japan, was found to have a 94 percent accuracy rate, researchers claim. Who needs endoscopic skills or microscopy skills now for...